Differential diagnosis between lymphoma-associated malignant pleural effusion and tuberculous pleural effusion.

Malignant pleural effusion (MPE) adenosine deaminase (ADA) lactate dehydrogenase (LDH) lymphoma tuberculous pleural effusion (TPE)

Journal

Annals of translational medicine
ISSN: 2305-5839
Titre abrégé: Ann Transl Med
Pays: China
ID NLM: 101617978

Informations de publication

Date de publication:
Aug 2019
Historique:
entrez: 27 9 2019
pubmed: 27 9 2019
medline: 27 9 2019
Statut: ppublish

Résumé

Lymphoma-associated malignant pleural effusions (L-MPE) can mimic tuberculous pleural effusion (TPE) characterized by lymphocytic exudate with high adenosine deaminase (ADA) levels. Furthermore, the low cytological yield of L-MPE makes differentiation between L-MPE and TPE more challenging. However, there are few data regarding differential diagnosis of L-MPE and TPE. All consecutive patients diagnosed with L-MPE or TPE between January 2011 and December 2016 were retrospectively recruited using the Electronic Medical Record database. Clinical symptoms and laboratory and pleural fluid data [including serum lactate dehydrogenase (LDH), C-reactive protein, and pleural fluid ADA levels] were compared between L-MPE and TPE. Useful variables in the differential diagnosis of L-MPE and TPE were evaluated by multivariate logistic regression analysis. Seventeen patients with L-MPE and 216 patients with TPE were included in this study. In the multivariate analysis, fever was negatively associated with L-MPE [odds ratio (OR): 0.175, 95% confidence interval (CI): 0.033-0.941, P=0.042], while serum LDH levels were positively associated with L-MPE (OR: 1.005, 95% CI: 1.003-1.007, P<0.001). Serum LDH >460 U/L provided a sensitivity of 76% and a specificity of 81% to distinguish L-MPE and TPE. In contrast, serum C-reactive protein and pleural fluid ADA levels were not significantly different between the groups. Patients with L-MPE and TPE present very similar clinical, laboratory, and pleural fluid characteristics. Fever and serum LDH levels may be helpful in guiding the differential diagnosis of L-MPE and TPE. Lymphoma should be kept in mind in the differential diagnosis in patients with lymphocytic pleural effusion and high ADA levels.

Sections du résumé

BACKGROUND BACKGROUND
Lymphoma-associated malignant pleural effusions (L-MPE) can mimic tuberculous pleural effusion (TPE) characterized by lymphocytic exudate with high adenosine deaminase (ADA) levels. Furthermore, the low cytological yield of L-MPE makes differentiation between L-MPE and TPE more challenging. However, there are few data regarding differential diagnosis of L-MPE and TPE.
METHODS METHODS
All consecutive patients diagnosed with L-MPE or TPE between January 2011 and December 2016 were retrospectively recruited using the Electronic Medical Record database. Clinical symptoms and laboratory and pleural fluid data [including serum lactate dehydrogenase (LDH), C-reactive protein, and pleural fluid ADA levels] were compared between L-MPE and TPE. Useful variables in the differential diagnosis of L-MPE and TPE were evaluated by multivariate logistic regression analysis.
RESULTS RESULTS
Seventeen patients with L-MPE and 216 patients with TPE were included in this study. In the multivariate analysis, fever was negatively associated with L-MPE [odds ratio (OR): 0.175, 95% confidence interval (CI): 0.033-0.941, P=0.042], while serum LDH levels were positively associated with L-MPE (OR: 1.005, 95% CI: 1.003-1.007, P<0.001). Serum LDH >460 U/L provided a sensitivity of 76% and a specificity of 81% to distinguish L-MPE and TPE. In contrast, serum C-reactive protein and pleural fluid ADA levels were not significantly different between the groups.
CONCLUSIONS CONCLUSIONS
Patients with L-MPE and TPE present very similar clinical, laboratory, and pleural fluid characteristics. Fever and serum LDH levels may be helpful in guiding the differential diagnosis of L-MPE and TPE. Lymphoma should be kept in mind in the differential diagnosis in patients with lymphocytic pleural effusion and high ADA levels.

Identifiants

pubmed: 31555687
doi: 10.21037/atm.2019.07.17
pii: atm-07-16-373
pmc: PMC6736794
doi:

Types de publication

Journal Article

Langues

eng

Pagination

373

Déclaration de conflit d'intérêts

Conflicts of Interest: The authors have no conflicts of interest to declare.

Références

Am J Respir Crit Care Med. 2000 Nov;162(5):1987-2001
pubmed: 11069845
Science. 2001 Apr 20;292(5516):504-7
pubmed: 11283355
Cancer Res. 1964 Apr;24:389-99
pubmed: 14147812
Chest. 2004 Jan;125(1):156-9
pubmed: 14718435
Respirology. 2004 Mar;9(1):66-9
pubmed: 14982604
Chest. 2004 Apr;125(4):1546-55
pubmed: 15078773
Nat Rev Cancer. 2004 Nov;4(11):891-9
pubmed: 15516961
Mayo Clin Proc. 2005 Jul;80(7):867-70
pubmed: 16007891
Diagn Cytopathol. 2006 May;34(5):335-47
pubmed: 16604559
Clin Infect Dis. 2006 Jun 1;42(11):1592-5
pubmed: 16652317
Respir Med. 2008 May;102(5):744-54
pubmed: 18222681
Respirology. 2010 Apr;15(3):451-8
pubmed: 20345583
Eur J Intern Med. 2010 Oct;21(5):419-23
pubmed: 20816597
J Bras Pneumol. 2012 Mar-Apr;38(2):181-7
pubmed: 22576425
S Afr Med J. 2012 Nov 02;103(1):32-3
pubmed: 23237121
Dis Mon. 2013 Feb;59(2):29-57
pubmed: 23374395
Acta Haematol. 2013;130(4):305-11
pubmed: 24008775
Acad Radiol. 2014 Jan;21(1):11-20
pubmed: 24331260
QJM. 2014 Nov;107(11):887-93
pubmed: 24854180
Br J Cancer. 2014 Jul 8;111(1):55-60
pubmed: 24874478
Haematologica. 2014 Dec;99(12):1817-25
pubmed: 25216682
Am J Clin Pathol. 2015 May;143(5):707-15
pubmed: 25873505
Lancet. 2016 Mar 19;387(10024):1211-26
pubmed: 26377143
Lung. 2016 Feb;194(1):147-53
pubmed: 26678281
Infection. 2017 Feb;45(1):59-65
pubmed: 27488820
Acta Cytol. 2016;60(4):354-364
pubmed: 27578145
Tuberc Respir Dis (Seoul). 2017 Jan;80(1):77-82
pubmed: 28119750
Lancet. 2017 Jul 15;390(10091):298-310
pubmed: 28153383
J Glob Oncol. 2016 Jan 13;2(1):26-29
pubmed: 28717679
J Infect. 2017 Dec;75(6):581-583
pubmed: 28804026
Am J Med Sci. 2017 Aug;354(2):125-130
pubmed: 28864369
Cancer. 1985 Aug 15;56(4):905-9
pubmed: 4016683
Acta Haematol. 1984;72(4):231-8
pubmed: 6438991
Leuk Res. 1981;5(3):215-22
pubmed: 6973675
Leuk Lymphoma. 1998 Oct;31(3-4):351-7
pubmed: 9869199
Br J Haematol. 1976 Dec;34(4):631-8
pubmed: 990193

Auteurs

Chang Ho Kim (CH)

Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.

Hong Geun Oh (HG)

Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.

Sang Yub Lee (SY)

Department of Radiology, School of Medicine, Kyungpook National University, Daegu, Korea.

Jae Kwang Lim (JK)

Department of Radiology, School of Medicine, Kyungpook National University, Daegu, Korea.

Yong Hoon Lee (YH)

Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.

Hyewon Seo (H)

Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.

Seung Soo Yoo (SS)

Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.

Shin Yup Lee (SY)

Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.

Seung Ick Cha (SI)

Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.

Jae Yong Park (JY)

Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.

Jaehee Lee (J)

Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.

Classifications MeSH